Abstract
Cyanobacteria are prolific producers of bioactive natural products. In this article, we outline some challenges faced in exploiting cyanobacteria for drug discovery, current solutions, and pathways forward to fully explore them for drug discovery.
Funding Information
  • National Center for Complementary and Integrative Health (T32AT010131)
  • Joint Genome Institute (DE-AC02-05CH11231)
  • Division of Cancer Prevention, National Cancer Institute (P01 CA125066)
  • National Institute of General Medical Sciences (5R01GM107550)
  • National Institute of General Medical Sciences (R15GM117541)
  • National Institute of General Medical Sciences (R35GM118290)
  • National Institute of General Medical Sciences (R35GM128742)
  • National Institute of General Medical Sciences (RM1GM145426)

This publication has 126 references indexed in Scilit: